A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Enumeration of circulating tumor cells (CTCs) obtained from minimally invasive blood samples has been well established as a valuable monitoring tool in metastatic and early breast cancer, as well as in several other cancer types. The gold standard technology for detecting CTCs in blood against a backdrop of millions of leukocytes is the FDA-approved CellSearch system (Janssen Diagnostics), which relies on EpCAM-based immunomagnetic separation. Secondary characterization of these cells could enable treatment selection based on specific targets in these cells, as well as providing a real time window into the metastatic process and offering unique insights into tumor heterogeneity. The objective of this study was to develop a method for downstream characterization of CTCs following isolation with the CellSearch system.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Cancer och onkologi
Originalspråkengelska
Artikelnummer126
TidskriftJournal of Translational Medicine
Volym13
Utgåva nummer1
StatusPublished - 2015
PublikationskategoriForskning
Peer review utfördJa

Nedladdningar

Ingen tillgänglig data

Related projects

Lisa Ryden, Kristina Aaltonen, Anna-Maria Larsson, Sara Baker, Kristina Lövgren, Anna Ebbesson, Anette Ahlin Gullers, Pär-Ola Bendahl, Sara Jansson & Charlotte Levin Tykjär Jörgensen

2011/01/01 → …

Projekt: Forskning

Lisa Ryden, Marlene Malmström & Emma Niméus

2000/01/03 → …

Projekt: Forskning

Visa alla (2)